SCHEMBL3247178

SCHEMBL3247178

Brc1ccc(-c2cnc(-c3cccs3)o2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 13/20 1.00
KDM4E B2RXH2 12/20 1.00
ALDH1A1 P00352 12/20 1.00
NPC1 O15118 11/20 1.00
HPGD P15428 10/20 1.00
SMN1; SMN2 Q16637 8/20 1.00
HSD17B10 Q99714 6/20 1.00
MAPT P10636 5/20 1.00
TSHR P16473 2/20 1.00
CASP3 P42574 2/20 1.00
SENP7 Q9BQF6 2/20 1.00
SENP8 Q96LD8 1/20 1.00
SENP6 Q9GZR1 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
CYP1A2 P05177 2/20 0.74
CYP2C19 P33261 2/20 0.74
CYP2D6 P10635 1/20 0.74
CYP2C9 P11712 1/20 0.74
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3246513 0.88 RAB9A (0.78) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL10715396 0.86 RAB9A (0.76) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL4879871 0.86 ALDH1A1 (0.75) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL3249622 0.85 RAB9A (1.00) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL10714331 0.85 KDM4E (0.74) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL10626253 0.82 ALDH1A1 (0.69) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL10716764 0.81 KDM4E (0.68) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL10137894 0.78 RAB9A (0.71) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL3254107 0.78 RAB9A (0.64) RAB9AKDM4EALDH1A1NPC1HPGD
SCHEMBL13930933 0.78 RAB9A (0.63) RAB9AKDM4EALDH1A1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2786992-A1 Compositions and methods for controlling nematodes Monsanto Technology LLC (US) 2014-10-08 EP claimed
US-20080015193-A1 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof AGRIUS GROUP, LLC. 2008-01-17 US claimed
US-10827753-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2020-11-10 US disclosed
US-10827753-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2020-11-10 US disclosed
US-20190343120-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-11-14 US disclosed
US-20190343120-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-11-14 US disclosed
US-20190327967-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-10-31 US disclosed
US-20190327967-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-10-31 US disclosed
US-10375958-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2019-08-13 US disclosed
US-10375958-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2019-08-13 US disclosed
US-20190021325-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES MONSANTO TECHNOLOGY LLC (US) 2019-01-24 US disclosed
US-8435999-B2 Compositions and methods for controlling nematodes MONSANTO TECHNOLOGY LLC (US) 2013-05-07 US disclosed
EP-2184989-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES Divergence, Inc. (US) 2010-05-19 EP disclosed
WO-2009023721-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES DIVERGENCE, INC. (US) 2009-02-19 WO disclosed
WO-2009023721-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES DIVERGENCE, INC. (US) 2009-02-19 WO disclosed
US-20090048311-A1 Compostions and Methods for Controlling Nematodes MONSANTO TECHNOLOGY LLC 2009-02-19 US disclosed
US-20090048311-A1 Compostions and Methods for Controlling Nematodes MONSANTO TECHNOLOGY LLC 2009-02-19 US disclosed
US-20090048311-A1 Compostions and Methods for Controlling Nematodes MONSANTO TECHNOLOGY LLC 2009-02-19 US disclosed
US-20080015193-A1 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof AGRIUS GROUP, LLC. 2008-01-17 US disclosed
WO-2007149395-A2 2,5-SUBSTITUTED OXAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AMPHORA DISCOVERY CORPORATION (US) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10827753-B2 Compositions and methods for controlling nematodes NOP2, ATL3, CYCS RAB9A 3412/4885KDM4E 2052/4885ALDH1A1 3430/4885
US-20190021325-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES NOP2, ATL3, CYCS RAB9A 3412/4885KDM4E 2052/4885ALDH1A1 3430/4885
US-20190343120-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES NOP2, ATL3, CYCS RAB9A 3412/4885KDM4E 2052/4885ALDH1A1 3430/4885
US-20090048311-A1 Compostions and Methods for Controlling Nematodes NOP2, MT-CO3, CLPX RAB9A 4578/4885KDM4E 2135/4885ALDH1A1 2842/4885
US-20080015193-A1 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof ATP5ME, ATP5MG, ATP5MK RAB9A 3960/4885KDM4E 2869/4885ALDH1A1 404/4885
US-10375958-B2 Compositions and methods for controlling nematodes NOP2, ATL3, CYCS RAB9A 3412/4885KDM4E 2052/4885ALDH1A1 3430/4885
US-20190327967-A1 COMPOSITIONS AND METHODS FOR CONTROLLING NEMATODES NOP2, ATL3, CYCS RAB9A 3412/4885KDM4E 2052/4885ALDH1A1 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.